Skip to main content
SpringerLink
Log in

Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?

  • Article
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

  1. Tübingen Ageing and Tumour Immunology Group, Section for Transplantation Immunology and Immunohaematology, Second Department of Internal Medicine, University of Tübingen Medical School, Otfried Müller-Strasse 10, D-72076 Tübingen, Germany e-mail: graham.pawelec@med.uni-tuebingen.de, Tel: +49-7071-2982805 Fax: +49-7071-294464 URL: http://www.medizin.uni-tuebingen.de/eucaps/, , , , , , DE

    Graham Pawelec

Authors
  1. Graham Pawelec
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 20 March 1999 / Accepted: 3 May 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pawelec, G. Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer?. Cancer Immunol Immunother 48, 343–345 (1999). https://doi.org/10.1007/s002620050584

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002620050584

Keywords

Search

Navigation